EGFR and lung adenocarcinoma: For patients initially diagnosed with EGFR-mutant advanced lung adenocarcinoma, concurrent brain metastasis was associated with severe morbidity, poor survival outcomes, and quality of life (Economopoulou and Mountzios, 2016).